Muscle Cell Mediated Therapy for Tongue Dysphagia: An Investigation of Cook MyoSite Autologous Muscle Derived Cells

Next Previous
Trial Profile

Muscle Cell Mediated Therapy for Tongue Dysphagia: An Investigation of Cook MyoSite Autologous Muscle Derived Cells

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs Autologous muscle-derived stem cell therapy Cook MyoSite (Primary)
  • Indications Oropharyngeal cancer; Squamous cell cancer
  • Focus Adverse reactions

    • Most Recent Events

    • 13 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 25 May 2017 Planned initiation date changed from 1 Sep 2016 to 1 Jun 2017.
    • 01 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top